Article
type: Class

Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

2022
type: Class

Entity
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

Conference Paper
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-01T15:44:13
publisher: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY
label: RDF description of SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY - http://research.umh.es/vivo/pub/comunicacion/243395

SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY
type: Article
type: Anualidad
related by: AutorExt:390687_2022-Comunicación:243395
RO_0002353: EULAR EUROPEAN CONGRESS OF RHEUMATOLOGY
type: Document
related by: Autor:4585-Comunicación:243395
type: Conference Paper
type: Information Content Entity
type: Entity
date time value: 243395 pubdate
most specific type: 2022
page start: 600
type: Continuant
most specific type: Conference Paper
included: Instituto Centro de Investigación Operativa 2022
included: Estadística, Matemáticas e Informática 2022
type: Congress communication
most specific type: Congress communication
page end: 600
type: Generically Dependent Continuant
type: Thing
type: 2022
related by: AutorExt:390686_2022-Comunicación:243395
included: Grupo de Investigación Aplicada en Agroquímica y Medio Ambiente 2022
ARG_2000028: 243395 vcard
included: Innovaciones en Productos Alimentarios 2022
included: Unidad Mixta de Investigación en Métodos Estadísticos Avanzados en Ciencias de la Salud UMH-FISABIO 2022

AutorExt:390687_2022-Comunicación:243395
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

EULAR EUROPEAN CONGRESS OF RHEUMATOLOGY
type: Entity
RO_0002234: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY
type: Conference
type: BFO_0000003
type: 2022
type: Event
type: Thing
type: BFO_0000015
type: Anualidad

Autor:4585-Comunicación:243395
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

Instituto Centro de Investigación Operativa 2022
type: InstituteReport
type: 2022
type: Anualidad
type: Thing
type: ResearchReport
includes: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

Estadística, Matemáticas e Informática 2022
type: 2022
type: Anualidad
type: DepartmentReport
type: Thing
type: ResearchReport
includes: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

AutorExt:390686_2022-Comunicación:243395
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

Grupo de Investigación Aplicada en Agroquímica y Medio Ambiente 2022
type: 2022
type: ResearchOrganizationReport
type: Anualidad
type: Thing
type: ResearchReport
includes: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

Innovaciones en Productos Alimentarios 2022
type: 2022
type: ResearchOrganizationReport
type: Anualidad
type: Thing
type: ResearchReport
includes: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

Unidad Mixta de Investigación en Métodos Estadísticos Avanzados en Ciencias de la Salud UMH-FISABIO 2022
type: 2022
type: ResearchOrganizationReport
type: Anualidad
type: Thing
type: ResearchReport
includes: SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY